Lacosamide Zentiva

Lacosamide, the active ingredient in Lacosamide Zentiva, is an anticonvulsant presented as a tablet for oral use. It is used as adjunctive therapy for partial‑onset seizures in patients with epilepsy. GNH USA supplies Lacosamide Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anticonvulsant used in the management of seizure disorders.

Partial‑onset seizures: Reduces seizure frequency when added to existing antiepileptic regimens. Monotherapy for partial‑onset seizures: Can be used alone to control focal seizures in patients who are newly diagnosed.

Lacosamide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness - Nausea - Headache - Fatigue - Diplopia (double vision) - Tremor

Serious or Rare Side Effects: - Cardiac arrhythmias (including PR interval prolongation) - Severe skin reactions such as Stevens‑Johnson syndrome - Suicidal thoughts or behavior - Acute pancreatitis - Hepatotoxicity

Before initiating Lacosamide, consider the following safety measures.

Cardiac monitoring: Assess baseline ECG and monitor for PR interval changes. Renal impairment: Adjust dosing in patients with severe renal dysfunction. Hepatic impairment: Use caution and consider dose adjustment in liver disease. Pregnancy and lactation: Evaluate risk‑benefit ratio as safety data are limited. Concomitant CNS depressants: Monitor for enhanced sedation or respiratory depression. Store at ambient temperature: Keep below 25°C in the original container, protect from moisture and direct sunlight.

Lacosamide can interact with several medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin): May reduce lacosamide plasma levels. - Concomitant use with other sodium‑channel blockers (e.g., carbamazepine, lamotrigine): Increases risk of cardiac conduction abnormalities.

Moderate Interactions (Monitor Closely): - Alcohol: May enhance central nervous system depression. - Opioids: Potential additive sedation. - Anticoagulants (e.g., warfarin): May require INR monitoring. - Antidepressants (e.g., SSRIs): Observe for increased dizziness or nausea.